Source:http://linkedlifedata.com/resource/pubmed/id/16001311
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2005-7-7
|
| pubmed:abstractText |
A review of the literature relating to the therapeutic potential of alpha2-adrenoceptor antagonists published between 1990 and 2000 is presented. Although extensively studied since the early 1970s in a wide spectrum of therapeutic applications, the distinction of alpha2-adrenoceptor subtypes and some emerging evidence concerning new applications in neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases, obesity and schizophrenia, have refreshed an interest in this class of agents.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
1369-7056
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
4
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
662-76
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
alpha2-Adrenoreceptor antagonists.
|
| pubmed:affiliation |
Centre de Recherche Pierre Fabre, Division de Chimie Medicinale III, 17 avenue Jean Moulin, F 81106, Castres, Cedex 06, France. patrice.mayer@pierre-fabre.com
|
| pubmed:publicationType |
Journal Article
|